亚太地区乳房再造市场预测至 2028 年 - COVID-19 影响和按技术(乳房下、乳晕周围、经腋窝和经脐)、类型(乳房植入物和植入配件)进行的区域分析;放置(双平面插入、腺下插入和肌肉下插入)、手术(立即手术、延迟手术和修正手术)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 131    |    Report Code: TIPRE00023482    |    Category: Life Sciences

Asia Pacific Breast Reconstruction Market

市场介绍

乳房再造是重建乳房形状和外观的手术方法,最常见于接受过手术的女性治疗乳腺癌。它包括自体组织、假体植入物或两者的混合,以重建看起来自然的乳房。乳房再造技术在过去几十年里得到了发展,并提供了适合乳腺癌女性个体需求的选择。

因此,乳腺癌的高患病率预计将在以下地区产生对乳房再造的巨大需求:未来几年,预计这将进一步推动乳房再造市场的发展。

亚太国家预计将面临由于不断增长的 COVID-19 带来的巨大挑战。考虑到当前的经济状况,由于疾病的爆发,医疗保健行业受到了严重影响。由于冠状病毒病例不断增加,许多研讨会和国际会议被推迟。例如,由于当前冠状病毒的蔓延,第九届亚太乳腺癌峰会已推迟到3月13日至15日举行。已经采取了限制性措施来控制这种流行病的传播,但是,在这种措施中,癌症患者并没有得到优先治疗。例如,根据日本2020年的报告,“在COVID-19大流行期间,超过一半的乳房手术和乳房重建不得不推迟,并且与大流行前相比,接受手术的人数也有所减少。”对乳腺癌患者的分诊并没有给这些患者带来任何不良的肿瘤学结果。 COVID-19对乳腺癌手术和乳房重建产生了重大影响,手术大幅推迟。除了整体卫生系统外,癌症护理服务系统也因冠状病毒爆发而面临挑战。

 

 

市场概况和动态

亚太地区乳房再造市场预计从2021年的1.177亿美元增长到2028年的1.849亿美元;预计 2021 年至 2028 年复合年增长率为 6.7%。乳腺癌是女性中最常见的癌症类型之一。其主要特征是乳房出现肿块、乳头内陷、乳房形状改变、乳头流出液体、皮肤出现红色或鳞状斑块、皮肤凹陷、乳头疼痛和肿胀。乳腺癌采用乳房切除术治疗,该手术包括通过外科手术切除整个乳房。乳房再造手术用于在乳房切除术后重建乳房。种植体重建和自体或皮瓣重建是这些手术中使用的两种主要技术。随着全世界乳腺癌患病率的不断增加,许多女性在乳房切除术后选择重建手术以恢复乳房的原始形状。据breastcancer.org称,截至2018年1月,美国有超过310万女性有乳腺癌病史,包括正在接受治疗的女性和过去接受过治疗的女性。此外,根据世界卫生组织(WHO)发表的一项研究,2020年全球约有230万女性新诊断出患有乳腺癌。此外,根据美国临床肿瘤学会杂志上发表的一项研究到 2020 年,大约每 29 名印度女性中就有 1 人在人生的某个阶段患有乳腺癌。乳腺癌患病率不断上升,加上人们对乳房切除术后乳房重建手术的偏好日益增加,预计将推动市场增长。

 

主要市场细分市场

从技术角度来看,乳房下细分市场在2020年亚太地区乳房再造市场中占据最大份额。从类型来看,乳房植入物细分市场占据了2020年亚太地区乳房再造市场的最大份额。 2020 年亚太地区乳房再造市场的最大份额。就放置而言,双平面插入部分占据了 2020 年亚太乳房再造市场的最大份额。就手术而言,即刻手术部分占据了更大的份额。 2020年乳房再造市场的市场份额。

 

主要来源和公司列出

准备本亚太地区乳房再造市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有 Allergan Plc

Mentor Worldwide LLC(强生子公司)

GC Aesthetics PLC

POLYTECH Health & ; Aesthetics GmbH

HANSBIOMED CO. LTD

Establishment Labs SA、广州万和塑料材料有限公司

Groupe Sebbin SAS。

 

< strong>购买报告的理由

  • 了解亚太地区乳房再造市场格局并确定最有可能保证丰厚回报的细分市场
  • 了解亚太地区乳房再造市场不断变化的竞争格局,保持领先地位
  • 有效规划并购通过识别最有可能销售的细分市场,与合作伙伴在亚太地区乳房再造市场进行交易
  • 通过对亚太地区乳房再造市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获取亚太地区各细分市场2021-2028年的市场收入预测

 

亚太地区乳房再造市场细分

 

作者 < /span>技术

  • 乳房下
  • 乳晕周围
  • 经腋窝
  • 经脐

作者类型

  • 乳房植入物
  • 植入物配件

 

 

< span>按位置

  • 双平面插入
  • 腺下插入
  • 肌肉下插入

 

通过 程序

  • 立即程序
  • 延迟程序
  • < li>修订程序

 

按国家/地区

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太地区其他地区

 

 

提及的公司

  1. Allergan Plc
  2. Mentor Worldwide LLC (强生公司的子公司Johnson)
  3. GC Aesthetics PLC
  4. POLYTECH Health & Aesthetics GmbH
  5. HANSBIOMED CO. LTD
  6. Establishment Labs SA
  7. Groupe Sebbin SAS
  8. 广州万和塑料材料有限公司< /li>
 

Asia Pacific Breast Reconstruction Strategic Insights

Strategic insights for Asia Pacific Breast Reconstruction involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-breast-reconstruction-market-strategic-framework.webp
Get more information on this report

Asia Pacific Breast Reconstruction Report Scope

Report Attribute Details
Market size in 2021 US$ 117.7 Million
Market Size by 2028 US$ 184.9 Million
Global CAGR (2021 - 2028) 6.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 技术
  • 乳房下
  • 乳晕周围
  • 腋窝
  • 脐带
By 类型
  • 乳房植入物
  • 植入物配件
By 放置
  • 双平面插入
  • 腺下插入
  • 肌肉下插入
By 程序
  • 立即程序
  • 延期程序
  • 修订程序
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Allergan Plc
  • Mentor Worldwide LLC ( Subsidiary of Johnson & Johnson)
  • GC Aesthetics PLC
  • POLYTECH Health & Aesthetics GmbH
  • HANSBIOMED CO. LTD
  • Establishment Labs S.A.
  • Groupe Sebbin SAS
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Get more information on this report

    Asia Pacific Breast Reconstruction Regional Insights

    The regional scope of Asia Pacific Breast Reconstruction refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-breast-reconstruction-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Breast Reconstruction Market

    1. Allergan Plc
    2. Mentor Worldwide LLC ( Subsidiary of Johnson & Johnson)
    3. GC Aesthetics PLC
    4. POLYTECH Health & Aesthetics GmbH
    5. HANSBIOMED CO. LTD
    6. Establishment Labs S.A.
    7. Groupe Sebbin SAS
    8. Guangzhou Wanhe Plastic Materials Co., Ltd.
    Frequently Asked Questions
    How big is the Asia Pacific Breast Reconstruction Market?

    The Asia Pacific Breast Reconstruction Market is valued at US$ 117.7 Million in 2021, it is projected to reach US$ 184.9 Million by 2028.

    What is the CAGR for Asia Pacific Breast Reconstruction Market by (2021 - 2028)?

    As per our report Asia Pacific Breast Reconstruction Market, the market size is valued at US$ 117.7 Million in 2021, projecting it to reach US$ 184.9 Million by 2028. This translates to a CAGR of approximately 6.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Breast Reconstruction Market report typically cover these key segments-

  • 技术 (乳房下, 乳晕周围, 腋窝, 脐带)
  • 类型 (乳房植入物, 植入物配件)
  • 放置 (双平面插入, 腺下插入, 肌肉下插入)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Breast Reconstruction Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Breast Reconstruction Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Breast Reconstruction Market?

    The Asia Pacific Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Allergan Plc
  • Mentor Worldwide LLC ( Subsidiary of Johnson & Johnson)
  • GC Aesthetics PLC
  • POLYTECH Health & Aesthetics GmbH
  • HANSBIOMED CO. LTD
  • Establishment Labs S.A.
  • Groupe Sebbin SAS
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Who should buy this report?

    The Asia Pacific Breast Reconstruction Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.